FDA could erase OTC exemption from device identifier rule

02/11/2013 | Clinica (subscription required)

Over-the-counter medical technologies might not be excluded from the unique device identifier rule being prepared for publication in June by the FDA. "There's a lot of interest in not seeing this exemption in the final rule, so we're taking this into account," said Jay Crowley, senior adviser on patient safety for the FDA.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA